SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of October, 2013

Commission File Number 1-15194

 

 

COMPANHIA DE BEBIDAS DAS AMÉRICAS-AMBEV
(Exact name of registrant as specified in its charter)
 

American Beverage Company-AMBEV
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 4 th Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1  

 

AMBEV REPORTS THIRD QUARTER 2013 RESULTS UNDER IFRS

São Paulo, October 31, 2013 – Companhia de Bebidas das Américas – Ambev [BOVESPA: AMBV4, AMBV3; NYSE: ABV, ABVc] announces today the results for the 2013 third quarter. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais  and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the three and nine months period ended September 30, 2013 filed with the CVM and submitted to the SEC.  For important disclaimers, please refer to page 4.

 Operating and Financial Highlights

Top line performance: Our net revenues increased 4.0%, with a volume decline of 3.1% being more than offset by 7.3% growth in net revenue per hectoliter (NR/Hl).  Accordingly, though industry softness in Brazil, Canada, and, to a lesser extent, Argentina, continued to impact volume performance, this was another quarter of top line growth in nearly all our divisions (Brazil Beer +0.8%, Brazil CSD & NANC +5.4%, HILA-ex +10.7%, LAS +14.8%, while Canada -0.1%) thanks to solid NR/Hl performance (Brazil Beer +6.0%, Brazil CSD & NANC +7.6%, HILA-ex +10.9%, LAS +15.1% and Canada +2.2%).

Cost of Goods Sold (COGS): COGS grew at 5.8%, with COGS/Hl increasing 9.3%.  Such performance represents an improvement over our H1 2013 results (COGS +9.0%; COGS/Hl +13.9%), and came mostly from our Brazilian business, where commodity hedges (primarily barley and aluminum) helped to soften pressure coming from currency hedges, higher industrial depreciation linked to capital expenditures, as well as packaging mix in Brazil Beer. 

Selling, General & Administrative (SG&A) expenses: SG&A expenses (excluding depreciation and amortization) improved significantly and were down 0.5%.  Such improvement is explained by commercial spend growing at a lower pace than H1 2013 (without compromising investments behind our brands and innovation) and by the savings generated from our cost management initiatives around “non-working money”, also helped by lower provisions related to variable compensation.  D istribution expenses where higher due mainly to the  greater weight of direct distribution in Brazil and inflationary pressures in Argentina.   

EBITDA, Gross margin and EBITDA margin: Our Normalized EBITDA grew 9.4% and corresponded to R$ 4,199.3 million, which also represents an important improvement if compared to the YoY growth we delivered in the first half of the year (+4.4%).  Gross margin performance improved in Q3 2013 (ie, -60 basis points vs. -120 bps in H1 2013) driven by less contraction in Brazil and expansion in our international divisions, while we delivered strong EBITDA margin expansion of 250 bps on the back of expansion across our business units.

 

Financial highlights - Ambev consolidated

R$ million

3Q12 Reference Base

3Q13

% As

Reported

%

Organic

YTD12 Reference Base

YTD13

% As

Reported

%

Organic

Total volumes

40,530.2

39,266.2

-3.1%

-3.1%

120,139.1

116,180.6

-3.3%

-3.9%

Beer

29,371.7

28,202.6

-4.0%

-4.0%

86,487.8

83,543.5

-3.4%

-4.2%

CSD and NANC

11,158.4

11,063.6

-0.8%

-0.8%

33,651.3

32,637.1

-3.0%

-3.2%

 

 

 

 

 

 

 

 

 

Net sales

8,036.0

8,462.6

5.3%

4.0%

22,097.1

23,738.5

7.4%

4.8%

Gross profit

5,414.6

5,646.4

4.3%

3.1%

14,863.3

15,707.2

5.7%

3.2%

Gross margin

67.4%

66.7%

-70 bps

-60 bps

67.3%

66.2%

-110 bps

-100 bps

EBITDA

3,777.8

4,192.4

11.0%

9.5%

10,088.0

11,003.0

9.1%

6.5%

EBITDA margin

47.0%

49.5%

250 bps

250 bps

45.7%

46.4%

70 bps

70 bps

Normalized EBITDA

3,787.4

4,199.3

10.9%

9.4%

10,124.4

11,016.2

8.8%

6.2%

Normalized EBITDA margin

47.1%

49.6%

250 bps

250 bps

45.8%

46.4%

60 bps

70 bps

Profit - Ambev holders

2,476.9

2,280.3

-7.9%

 

6,695.0

6,506.2

-2.8%

 

Normalized profit - Ambev holders

2,486.5

2,287.2

-8.0%

 

6,731.4

6,519.4

-3.1%

 

No. of share outstanding (millions)

3,126.2

3,132.3

 

 

3,126.2

3,132.3

 

 

EPS (R$/shares)

0.79

0.73

-8.1%

 

2.14

2.08

-3.0%

 

Normalized EPS

0.80

0.73

-8.2%

 

2.15

2.08

-3.3%

 

 

Note: Earnings p er share calculation is based on outstanding shares (total existing shares excluding shares held in treasury).

This press release segregates the impact of organic changes from those arising from changes in scope or currency translation. Scope changes represent the impact of acquisitions and divestitures, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Unless stated, p ercentage changes in this press release are both organic and normalized in nature. Whenever used in this document, the term “normalized” refers to performance measures (EBITDA, EBIT, Profit, EPS) before special items adjustments. Special items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company’s performance. Comparisons, unless otherwise stated, refer to the third quarter of 2012 (Q3 2012). Values in this release may not add up due to rounding.


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  2  

 

Operating Cash generation and Profit: Cash generated from our operations improved 7.4%, totalling R$ 4,689.8 million.  Our Normalized Profit was R$ 2,287.2 million, declining 8.0% mostly impacted by higher net finance expenses and a greater effective tax rate. Normalized Earnings Per Share (EPS) corresponded to R$ 0.73 (-8.2% vs. Q3 2012).

 

CAPEX, Pay-out and Financial discipline: We invested approximately R$ 1 billion during the quarter in capex (R$ 2.3 billion thru September 30), of which R$ 847 million were carried out in Brazil.  In terms of pay-out, on September 27 we paid out approximately R$ 2 billion in dividends, bringing our pay-out this year to R$ 7.1 billion in dividends and IOC (vs. R$ 3.8 billion during the same period in 2012), and we also reduced our net cash position to R$ 2,399.7 million since December 31, 2012.

 

 Management Comments

If the second quarter was a good first step, our third quarter performance confirms that we are on the right track towards our objective of improving EBITDA performance for the remainder of 2013.  Our consolidated EBITDA was up 9.4% in the quarter (following growth of 4.4% in H1 2013), with Brazil Beer EBITDA up 7.3% (after 4.4% growth in the first half).  Industry volumes did indeed remain challenging across our main markets, particularly Brazil.  On the other hand, however, solid net revenue per hectoliter results, coupled with better COGS/Hl and SG&A performance as compared to the first half of the year enabled us to deliver stronger EBITDA growth and EBITDA margin expansion for the year.

Breaking down the results by division:

·          Brazil .  Our Brazilian operations delivered an EBITDA of R$ 2,820.7 million (+8.0%).  Gross margin contracted 80 bps, which marks an improvement against the first half of the year, while EBITDA margin expanded 330 bps, reaching 54.2%.

o     Brazil Beer net revenue grew 0.8%, with volumes declining 5.0% but NR/Hl performance remaining solid by growing 6.0%. 

§   We estimate the Brazilian beer industry declined 4.3% in the third quarter, which is evidence of the fact that even though there was some continued improvement in terms of food inflation and disposable income, the consumer environment remains challenging.  In addition, we lacked the incremental volumes from the FIFA Confederations Cup in Q2 and weather was also not helpful during the quarter.

§   The average market share for the quarter was 68.0%, which represents a sequential loss of 10 bps (and a 50 bps decline YoY, as we still faced a difficult comp against last year). 

§   Net revenue per hectoliter increased 6.0% against a very tough comp (+18.3% in Q3 2012), positively impacted by pricing, increased weight of direct distribution as well as greater weight of premium volumes.

§   Our commercial plan continued to make steady progress:

·          the top four commercial priorities all performed well, with volumes related to our innovation (led by the 550 ml can and aluminum bottles for Skol and Brahma, as well as the Brahma zero alcohol line extension) and premiumization (led by Budweiser, Stella Artois and Original) strategies growing well ahead of the industry (volumes for the 1 liter and the 300 ml returnable glass bottles likewise), while our market share in the North & Northeast posted another quarter of growth; and,

·          our pack price strategy once again delivered great results as we try to deliver to consumers different pack sizes and price propositions in a profitable way: for instance, growth of the 1 liter and the 300 ml returnable glass bottles helped us increase the weight of returnables in the off-premise channel for another quarter, and the execution of our revenue management initiatives continued to make progress as planned.

o     As for Brazil CSD & NANC, net revenue grew 5.4%, with an industry driven 2.0% decline in volumes being offset by a 7.6% growth in NR/Hl.  In terms of our commercial hightlights, Guaraná Antarctica reached an all-time high market share of 10% during the quarter, which clearly shows that the positive momentum for the brand continues thanks to continued investment on innovation behind the brand. 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  3  

 

o     On the costs side, Brazil COGS/hl grew 8.7% in Q3 2013 (Brazil Beer: +8.5%; Brazil CSD&NANC: +10.0%).  Brazil Beer COGS/hl results improved when compared to the first half of the year as a result of the continued tailwind of our commodity hedges helping offset the adverse effect coming from our currency hedges, higher industrial depreciation and changes in package mix.  In Brazil CSD & NANC, with the tough comparison we faced in Q2 2013 no longer a factor, COGS/Hl also grew less than in H1 2013. 

o     SG&A (excluding depreciation and amortization) was 2.4% lower than in the third quarter of 2012, which shows we are headed in the right direction in terms of our initiatives to protect the profitability of our business.  Our sales and marketing investments in the third quarter declined slightly, though we did not refrain from investing in our top commercial priorities, such as premium and innovation.  Also, the combination of cost saving initiatives around “non-working money” delivering as planned and lower variable compensations accruals as compared to last year led to lower administrative expenses, while the higher distribution expenses resulted primarily from the increased weight of direct distribution.   

·          HILA-ex .  In our Caribbean and Central American operations EBITDA totalled R$ 121.8 million (+37.5%), with gross margin expansion of 40 bps, and EBITDA margin expanding 630 bps to 32.2%.   

o     Our HILA-ex business continues to deliver great results: we continued to find further synergies in the Dominican Republic, while continuing to invest behind Presidente, innovating in the marketplace and working around premiumization, and in Guatemala, the third quarter was another quarter marked by consistent volume and market share, which once more reached new heights.  Top line grew 10.7% thanks to net revenue per hectoliter improving 10.9% versus Q3 2012.  These results were more than enough to offset the slight volumes decline (-0.2%) given the tougher industry in the Dominican Republic. 

·          LAS .  Our operations in LAS delivered EBITDA of R$ 674.8 million in Q3 2013 (+20.3%).  Gross margin expanded 60 bps and EBITDA margin expanded 190 bps to arrive at 41.5%.

o     Our year-over-year volume performance in LAS continued to improve in the third quarter: -0.3% as compared to -6.4% during H1 2013 despite the challenging environment in Argentina.  LAS Beer volumes were down 2.0% as compared to last year (vs. -5.3% in the first half), but LAS CSD volumes actually grew 2.2% (which compares to -7.8% in the first six months of the year).  Meanwhile, net revenue performance remained solid, increasing 14.8% (+14.6% for LAS Beer; +15.1% for LAS CSD & NANC).  On the commercial side, premium and innovation continued to lead the way with line extensions for the Quilmes family (eg, Quilmes 1890) and Stella Artois (eg, Stella Artois Noire) helping us deliver improved market share in Argentin a while brand preference remains healthy.

·          Canada .  EBITDA increased by 0.6% in the quarter, reaching R$ 582 million.  Labatt also delivered both gross and EBITDA margins expansion, 20 bps and 30 bps, respectively.  EBITDA margin was 46.6%.

o     Our Canadian business also showed improved performance as compared to the first half of the year: though volumes declined 2.2% in the quarter predominantly driven by continued industry softness (driven primarly by poor weather and the Quebec taxation hikes), market share remained sequentially flat and NR/Hl grew 2.2%, highlighting that the strength of our brands is allowing us to maintain share while implementing our revenue management strategy.  Innovation behind our focus brands proved once again to be a key component of our commercial strategy: the launch of Budweiser Black Crown, combined with the continued contributions from earlier innovation such as Bud Light Platinum and Bud Lime Lime-a-Rita, led to market share improvements for both the Budweiser and Bud Light families.

 

  2013 Outlook

 

The execution during the third quarter of our revised plan for the year allowed us to improve our year-over-year EBITDA performance as compared to Q1 and Q2 2013 despite an environment that remains challenging. 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  4  

 

As we set out to deliver a strong finish for the year, the resolve of our team and the disciplined execution of the commercial initiatives such as the pack price strategy, which has delivered great results since the first quarter, will once again be decisive.  In addition, the Brazilian Federal Government’s decision not to further increase excise taxes in 2013 is great news, as it should be supportive, for volumes and creates a more appropriate environment for us to keep our record CAPEX investment plans in place.

Our expectations for the year in Brazil remain mostly unchanged: given volume performance in the quarter and our outlook for Q4 2013, we now expect the beer industry to be at the lower end of the flat to low single-digit range we expected for the year; on the other hand, our expectations for net revenue/Hl (ie, high-single digits for the year), COGS/Hl (ie, high-single or low double-digits as mentioned before, with “high teens” in Brazil CSD & NANC), cash SG&A (below inflation for the year), and capital expenditures (around R$ 3.0 billion of capital expenditures) all stand.

Recent Events

On October 30, 2013, Ambev S.A. obtained its registration as a public company with the Comissão de Valores Mobiliários – CVM in Brazil.  As a result, and as previously disclosed, the company will now move to list its shares (and respective ADSs) on the BM&FBovespa S.A. – Bolsa de Valores Mercadorias e Futuros and on the New York Stock Exchange, respectively, which is expected to take place around mid- November, 2013.

DISCLAIMERS

In view of the stock swap merger involving Companhia de Bebidas das Américas – Ambev and Ambev S.A., which was approved by shareholders on July 30, 2013, we have also prepared the consolidated financial statements of Ambev S.A., including Companhia de Bebidas das Américas – Ambev as Ambev S.A.’s wholly-owned subsidiary.  Moreover, since the stock swap merger involved entities under common control, the predecessor cost accounting method was applied to all periods presented for comparability purposes.  For further information, please refer to footnote 1(c) to the quarterly financial information of Ambev S.A.

The operational and financial information contained herein refer to Companhia de Bebidas das Américas – Ambev (unless otherwise expressly stated herein ) .  The quarterly financial information related to Ambev S.A. for the period ending on September 30, 2013 were also filed with the CVM and submitted to the SEC.  For further information on Ambev S.A.’s operational and financial information, please refer to the CVM’s Sistema de Envio de Informações Periódicas e Eventuais – IPE at www.cvm.gov.br or the SEC’s EDGAR at www.sec.gov .  

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  5  

 

 

  Ambev Consolidated Income Statement

 

 

Consolidated income statement

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Net revenue

8,036.0

(9.6)

116.8

319.4

8,462.6

5.3%

4.0%

Cost of goods sold (COGS)

(2,621.5)

(3.2)

(38.4)

(153.1)

(2,816.2)

7.4%

5.8%

Gross profit

5,414.6

(12.8)

78.3

166.3

5,646.4

4.3%

3.1%

Selling, general and administrative (SG&A)

(2,340.1)

15.8

(35.2)

2.4

(2,357.1)

0.7%

-0.1%

Other operating income

251.9

(0.1)

1.8

140.8

394.3

56.6%

55.9%

Normalized operating income
(normalized EBIT)

3,326.3

2.9

44.9

309.4

3,683.6

10.7%

9.3%

Special items above EBIT

(9.6)

(0.0)

(0.6)

3.3

(6.9)

nm

-34.4%

Net finance results

(366.8)

 

 

 

(496.1)

35.2%

 

Share of results of associates

0.0

 

 

 

3.9

nm

 

Income tax expense

(448.2)

 

 

 

(848.9)

89.4%

 

Profit

2,501.7

 

 

 

2,335.5

-6.6%

 

Attributable to Ambev holders

2,476.9

 

 

 

2,280.3

-7.9%

 

Attributable to non-controlling interests

24.8

 

 

 

55.2

122.5%

 

Normalized profit

2,511.3

 

 

 

2,342.4

-6.7%

 

Attributable to Ambev holders

2,486.5

 

 

 

2,287.2

-8.0%

 

 

 

 

 

 

 

 

 

Normalized EBITDA

3,787.4

3.9

51.9

356.1

4,199.3

10.9%

9.4%

 

Consolidated income statement

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Net revenue

22,097.1

229.6

361.8

1,050.1

23,738.5

7.4%

4.8%

Cost of goods sold (COGS)

(7,233.8)

(103.1)

(125.8)

(568.5)

(8,031.3)

11.0%

7.9%

Gross profit

14,863.3

126.5

235.9

481.5

15,707.2

5.7%

3.2%

Selling, general and administrative (SG&A)

(6,567.3)

(28.4)

(124.7)

(458.4)

(7,178.8)

9.3%

7.0%

Other operating income

560.3

(4.1)

5.9

440.3

1,002.6

78.9%

78.6%

Normalized operating income
(normalized EBIT)

8,856.3

94.0

117.1

463.5

9,531.0

7.6%

5.2%

Special items above EBIT

(36.4)

(1.3)

(0.3)

24.8

(13.2)

-63.8%

nm

Net finance results

(635.3)

 

 

 

(1,005.0)

58.2%

 

Share of results of associates

0.1

 

 

 

5.7

nm

 

Income tax expense

(1,419.4)

 

 

 

(1,883.2)

32.7%

 

Profit

6,765.3

 

 

 

6,635.3

-1.9%

 

Attributable to Ambev holders

6,695.0

 

 

 

6,506.2

-2.8%

 

Attributable to non-controlling interests

70.3

 

 

 

129.0

83.6%

 

Normalized profit

6,801.7

 

 

 

6,648.4

-2.3%

 

Attributable to Ambev holders

6,731.4

 

 

 

6,519.4

-3.1%

 

 

 

 

 

 

 

 

 

Normalized EBITDA

10,124.4

126.4

137.8

627.6

11,016.2

8.8%

6.2%

 

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  6  

 

  Ambev Consolidated Results

 

The combination of Ambev’s operations in Latin America North (LAN), Latin America South (LAS) and Canada’s business units, eliminating intercompany transactions, comprises our consolidated financial statements. The figures shown below are on an as-reported basis.

Volume (million hectoliters)

 

Net revenues per HL (R$)

COGS per HL (R$)

 

 

Normalized EBITDA (R$ MM)

Normalized EBITDA margin (%)

 

 

 

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  7  

 

 

  Ambev Consolidated

We delivered during the quarter R$ 4,199.3 million of Normalized EBITDA (+9.4%), with net revenues growing 4.0%, COGS rising 5.8% and SG&A (excluding depreciation and amortization) actually declining 0.5%.  Gross margins contracted 60 bps to 66.7%, but EBITDA margin expanded 250 bps to 49.6%.  Year to date, EBITDA grew 6.2%.

 

Ambev results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

40,530.2

-

-

(1,264.0)

39,266.2

-3.1%

-3.1%

Net revenue

8,036.0

(9.6)

116.8

319.4

8,462.6

5.3%

4.0%

Net revenue/hl

198.3

(0.2)

3.0

14.5

215.5

8.7%

7.3%

COGS

(2,621.5)

(3.2)

(38.4)

(153.1)

(2,816.2)

7.4%

5.8%

COGS/hl

(64.7)

(0.1)

(1.0)

(6.0)

(71.7)

10.9%

9.3%

Gross profit

5,414.6

(12.8)

78.3

166.3

5,646.4

4.3%

3.1%

Gross margin

67.4%

 

 

 

66.7%

-70 bps

-60 bps

SG&A excl. deprec.&amort.

(2,175.2)

16.0

(34.3)

11.5

(2,181.9)

0.3%

-0.5%

SG&A deprec.&amort.

(164.9)

(0.2)

(0.9)

(9.2)

(175.2)

6.3%

5.5%

SG&A total

(2,340.1)

15.8

(35.2)

2.4

(2,357.1)

0.7%

-0.1%

Other operating income

251.9

(0.1)

1.8

140.8

394.3

56.6%

55.9%

Normalized EBIT

3,326.3

2.9

44.9

309.4

3,683.6

10.7%

9.3%

Normalized EBIT margin

41.4%

 

 

 

43.5%

210 bps

210 bps

Normalized EBITDA

3,787.4

3.9

51.9

356.1

4,199.3

10.9%

9.4%

Normalized EBITDA margin

47.1%

 

 

 

49.6%

250 bps

250 bps

 

Ambev results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

120,139.1

780.5

-

(4,739.0)

116,180.6

-3.3%

-3.9%

Net revenue

22,097.1

229.6

361.8

1,050.1

23,738.5

7.4%

4.8%

Net revenue/hl

183.9

0.7

3.1

16.6

204.3

11.1%

9.0%

COGS

(7,233.8)

(103.1)

(125.8)

(568.5)

(8,031.3)

11.0%

7.9%

COGS/hl

(60.2)

(0.5)

(1.1)

(7.4)

(69.1)

14.8%

12.2%

Gross profit

14,863.3

126.5

235.9

481.5

15,707.2

5.7%

3.2%

Gross margin

67.3%

 

 

 

66.2%

-110 bps

-100 bps

SG&A excl. deprec.&amort.

(6,110.8)

(21.2)

(120.1)

(416.4)

(6,668.5)

9.1%

6.8%

SG&A deprec.&amort.

(456.5)

(7.2)

(4.6)

(42.0)

(510.3)

11.8%

9.2%

SG&A total

(6,567.3)

(28.4)

(124.7)

(458.4)

(7,178.8)

9.3%

7.0%

Other operating income

560.3

(4.1)

5.9

440.3

1,002.6

78.9%

78.6%

Normalized EBIT

8,856.3

94.0

117.1

463.5

9,531.0

7.6%

5.2%

Normalized EBIT margin

40.1%

 

 

 

40.1%

bps

20 bps

Normalized EBITDA

10,124.4

126.4

137.8

627.6

11,016.2

8.8%

6.2%

Normalized EBITDA margin

45.8%

 

 

 

46.4%

60 bps

70 bps

 

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  8  

 

  Latin America North (LAN)

Our LAN region i-ncludes Beer Brazil, CSD & NANC Brazil and HILA-ex operations.  LAN EBITDA for the quarter totalled R$ 2,942.5 million (+8.9%), with an EBITDA margin expansion of 330 bps to 52.7%.  This improvement in results comes from solid net revenue per hectoliter growth (+6.3%), lower growth rate for COGS and COGS/Hl versus H1 2013 (+4.6% and +9.0%, respectively) and declining SG&A (-2.3%), with Brazil CSD & NANC EBITDA resuming growth in a relevant way, as well as important contributions from HILA-ex.  For the first nine months of the year LAN delivered an EBITDA of R$ 7,784.3 million (+5.7%).

As previously mentioned, as from January 1, 2013 the results of our Peruvian and Ecuadorian operations are reported as part of Latin America South.  To that effect, we have included restated figures for LAN and LAS, as if this change had been in place since January 1, 2012.  

 

LAN results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

29,673.8

-

-

(1,179.2)

28,494.6

-4.0%

-4.0%

Net revenue

5,447.3

8.5

19.4

111.2

5,586.4

2.6%

2.0%

Net revenue/hl

183.6

0.3

0.7

11.5

196.0

6.8%

6.3%

COGS

(1,709.7)

(3.2)

(9.9)

(79.3)

(1,802.1)

5.4%

4.6%

COGS/hl

(57.6)

(0.1)

(0.3)

(5.2)

(63.2)

9.8%

9.0%

Gross profit

3,737.6

5.3

9.5

31.9

3,784.3

1.2%

0.9%

Gross margin

68.6%

 

 

 

67.7%

-90 bps

-80 bps

SG&A excl. deprec.&amort.

(1,498.1)

(2.1)

(6.2)

44.5

(1,461.8)

-2.4%

-3.0%

SG&A deprec.&amort.

(121.1)

(0.2)

(0.6)

(6.9)

(128.8)

6.3%

5.7%

SG&A total

(1,619.2)

(2.3)

(6.8)

37.6

(1,590.6)

-1.8%

-2.3%

Other operating income

242.6

(0.1)

(0.1)

146.8

389.3

60.4%

60.5%

Normalized EBIT

2,361.0

2.9

2.6

216.4

2,582.9

9.4%

9.2%

Normalized EBIT margin

43.3%

 

 

 

46.2%

290 bps

310 bps

Normalized EBITDA

2,694.3

3.9

4.9

239.4

2,942.5

9.2%

8.9%

Normalized EBITDA margin

49.5%

 

 

 

52.7%

320 bps

330 bps

 

LAN results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

86,219.6

780.5

-

(3,314.0)

83,686.1

-2.9%

-3.8%

Net revenue

14,973.1

275.4

37.9

558.2

15,844.7

5.8%

3.7%

Net revenue/hl

173.7

1.6

0.5

13.6

189.3

9.0%

7.8%

COGS

(4,700.2)

(103.1)

(20.4)

(408.2)

(5,232.0)

11.3%

8.7%

COGS/hl

(54.5)

(0.7)

(0.2)

(7.1)

(62.5)

14.7%

13.0%

Gross profit

10,272.9

172.3

17.5

150.0

10,612.6

3.3%

1.5%

Gross margin

68.6%

 

 

 

67.0%

-160 bps

-150 bps

SG&A excl. deprec.&amort.

(4,154.8)

(67.0)

(13.3)

(288.0)

(4,523.0)

8.9%

6.9%

SG&A deprec.&amort.

(345.3)

(7.2)

(1.3)

(37.6)

(391.4)

13.4%

10.9%

SG&A total

(4,500.0)

(74.2)

(14.6)

(325.6)

(4,914.4)

9.2%

7.2%

Other operating income

559.5

(4.1)

0.0

462.3

1,017.8

81.9%

82.6%

Normalized EBIT

6,332.3

94.0

2.9

286.7

6,716.0

6.1%

4.5%

Normalized EBIT margin

42.3%

 

 

 

42.4%

10 bps

30 bps

Normalized EBITDA

7,239.8

126.4

6.9

411.2

7,784.3

7.5%

5.7%

Normalized EBITDA margin

48.4%

 

 

 

49.1%

70 bps

90 bps

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  9  

 

 

  Ambev Brazil

We delivered R$ 2,820.7 million (+8.0%) of Normalized EBITDA in Brazil, with an EBITDA margin expansion of 330 bps to 54.2%.  Year to date, EBITDA has grown 5.1% and EBITDA margin corresponded to 50.4%, which represents an expansion of 80 bps.

Brazil’s top line performance remained under pressure in terms of volumes (-4.2%; YTD: -4.1%) given the challenging environment that remains despite some continued improvements in food inflation and disposable income, as well as unhelpful weather.  Our NR/Hl results, however, continued to deliver strong results and grew 5.9%, giving us 7.9% so far this year, which falls within our high single-digit guidance for FY 2013.

COGS/Hl continued to grow by less year-over-year than prior quarters, posting an increase of 8.7% (vs. 15.9% in H1 2013) bringing the YTD performance to 13.3%, which is slightly above our guidance of high single to low double-digit growth for the full year.  SG&A (excluding depreciation and amortization) performance also improved, declining by 2.4%, which is consistent with our expectation of cash SG&A growing below inflation for the year.  Year-to-date, SG&A (excluding depreciation and amortization) is up 7.7%.

 

Ambev Brazil results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

28,083.8

   

(1,176.5)

26,907.3

-4.2%

-4.2%

Net revenue

5,131.2

   

77.3

5,208.5

1.5%

1.5%

Net revenue/hl

182.7

   

10.9

193.6

5.9%

5.9%

COGS

(1,560.0)

   

(64.5)

(1,624.5)

4.1%

4.1%

COGS/hl

(55.5)

   

(4.8)

(60.4)

8.7%

8.7%

Gross profit

3,571.1

   

12.8

3,584.0

0.4%

0.4%

Gross margin

69.6%

   

  

68.8%

-80 bps

-80 bps

SG&A excl. deprec.&amort.

(1,388.1)

   

32.9

(1,355.2)

-2.4%

-2.4%

SG&A deprec.&amort.

(109.6)

    

(9.2)

(118.9)

8.4%

8.4%

SG&A total

(1,497.7)

    

23.6

(1,474.0)

-1.6%

-1.6%

Other operating income

242.8

    

148.0

390.8

60.9%

60.9%

Normalized EBIT

2,316.3

    

184.4

2,500.7

8.0%

8.0%

Normalized EBIT margin

45.1%

    

  

48.0%

290 bps

290 bps

Normalized EBITDA

2,612.1

   

208.6

2,820.7

8.0%

8.0%

Normalized EBITDA margin

50.9%

    

 

54.2%

330 bps

330 bps

 

Ambev Brazil results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

82,864.5

   

(3,382.5)

79,482.0

-4.1%

-4.1%

Net revenue

14,378.4

   

500.4

14,878.8

3.5%

3.5%

Net revenue/hl

173.5

   

13.7

187.2

7.9%

7.9%

COGS

(4,395.1)

   

(383.0)

(4,778.1)

8.7%

8.7%

COGS/hl

(53.0)

   

(7.1)

(60.1)

13.3%

13.3%

Gross profit

9,983.3

   

117.4

10,100.7

1.2%

1.2%

Gross margin

69.4%

   

  

67.9%

-150 bps

-150 bps

SG&A excl. deprec.&amort.

(3,923.2)

   

(301.4)

(4,224.5)

7.7%

7.7%

SG&A deprec.&amort.

(321.0)

   

(37.1)

(358.1)

11.6%

11.6%

SG&A total

(4,244.2)

   

(338.5)

(4,582.6)

8.0%

8.0%

Other operating income

558.3

    

463.3

1,021.6

83.0%

83.0%

Normalized EBIT

6,297.4

   

242.2

6,539.6

3.8%

3.8%

Normalized EBIT margin

43.8%

   

   

44.0%

20 bps

20 bps

Normalized EBITDA

7,134.1

   

366.6

7,500.7

5.1%

5.1%

Normalized EBITDA margin

49.6%

   

   

50.4%

80 bps

80 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 10  

 

 

  Beer Brazil

EBITDA for Beer Brazil during the quarter totalled R$ 2,348.0 million (+7.3%) and EBITDA margin was 54.2% (+330 bps), while for the year, EBITDA increased 5.5% and EBITDA margin reached 51.3% (+120 bps).

The beer industry fell 4.3%, still impacted by food inflation growing ahead of general inflation and disposable income increasing by less than the previous year, though in both cases to a lesser extent than what we witnessed in H1 2013, a nd weather was not helpful.  Our average market share for the quarter was nearly flat sequentially (-10 bps) at 68.0% (-50 bps vs. Q3 2012), and NR/Hl remained strong against the toughest comp of the year (+6.0% vs. +18.3% in Q3 2012) thanks to pricing, premium volume mix and greater weight of direct distribution, allowing us to offset the short term volume softness and still deliver net revenue growth (+0.8%) in the quarter. 

COGS/Hl performance improved by rising 8.5% (as compared to +15.9% in H1 2013) thanks to commodity hedges offsetting more of the headwinds from currency hedges, changes in package mix and higher industrial depreciation.  And SG&A (excl. depreciation and amortization) expenses were 0.1% lower than Q3 2012, favorably impacted by phasing of sales and marketing investments (ie, frontloading into H1), lower variable compensation accruals and successful implementation of our “non-working money” savings initiatives, though distribution expenses were higher due to the higher weight of direct distribution.

 

Beer Brazil results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

20,659.8

   

(1,024.7)

19,635.1

-5.0%

-5.0%

Net revenue

4,299.3

   

32.6

4,331.9

0.8%

0.8%

Net revenue/hl

208.1

   

12.5

220.6

6.0%

6.0%

COGS

(1,211.4)

   

(37.4)

(1,248.8)

3.1%

3.1%

COGS/hl

(58.6)

   

(5.0)

(63.6)

8.5%

8.5%

Gross profit

3,087.9

   

(4.8)

3,083.1

-0.2%

-0.2%

Gross margin

71.8%

   

 

71.2%

-60 bps

-60 bps

SG&A excl. deprec.&amort.

(1,214.5)

   

0.9

(1,213.6)

-0.1%

-0.1%

SG&A deprec.&amort.

(83.3)

   

(6.9)

(90.2)

8.3%

8.3%

SG&A total

(1,297.8)

   

(6.0)

(1,303.8)

0.5%

0.5%

Other operating income

158.4

   

147.2

305.6

92.9%

92.9%

Normalized EBIT

1,948.5

   

136.4

2,084.9

7.0%

7.0%

Normalized EBIT margin

45.3%

   

 

48.1%

280 bps

280 bps

Normalized EBITDA

2,187.6

   

160.4

2,348.0

7.3%

7.3%

Normalized EBITDA margin

50.9%

   

 

54.2%

330 bps

330 bps

 

Beer Brazil results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

61,190.9

   

(2,863.1)

58,327.7

-4.7%

-4.7%

Net revenue

12,027.4

   

368.1

12,395.4

3.1%

3.1%

Net revenue/hl

196.6

   

16.0

212.5

8.1%

8.1%

COGS

(3,378.0)

   

(267.5)

(3,645.5)

7.9%

7.9%

COGS/hl

(55.2)

   

(7.3)

(62.5)

13.2%

13.2%

Gross profit

8,649.4

   

100.6

8,749.9

1.2%

1.2%

Gross margin

71.9%

   

 

70.6%

-130 bps

-130 bps

SG&A excl. deprec.&amort.

(3,449.7)

   

(274.3)

(3,724.0)

8.0%

8.0%

SG&A deprec.&amort.

(243.9)

   

(27.7)

(271.6)

11.4%

11.4%

SG&A total

(3,693.7)

   

(302.0)

(3,995.7)

8.2%

8.2%

Other operating income

399.7

   

419.3

819.0

104.9%

104.9%

Normalized EBIT

5,355.4

   

217.8

5,573.3

4.1%

4.1%

Normalized EBIT margin

44.5%

   

 

45.0%

50 bps

50 bps

Normalized EBITDA

6,023.6

   

330.7

6,354.3

5.5%

5.5%

Normalized EBITDA margin

50.1%

   

 

51.3%

120 bps

120 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 1  

 

 

 

  CSD & NANC Brazil

In Brazil CSD & NANC, EBITDA  was R$ 472.7 million (+11.3%) in the quarter, with an expansion of 290 bps in EBITDA margin to 53.9%.  Year-to-date, EBITDA is up 3.2% and EBITDA margin is 46.2% (-100 bps).

Top line growth remained steady (+5.4%) and in line with the first half of the year (+5.8%) despite volume decline of 2.0% for the most part because of the challenging environment that also impacted the beer industry.  Market share grew 30 bps sequentially, averaging 18.4% for the quarter (-10 bps YoY) thanks to Guaraná Antarctica’s performance.  The brand’s equity and market share have consistently improved as a result of innovation (eg, 1 liter returnable glass bottle) and investments behind the brand (eg, targeted promotions). NR/Hl remained solid, posting 7.6% growth. 

As far as costs and expenses are concerned, COGS/Hl and SG&A results were also better than H1 2013, with COGS/Hl up 10.0% (+14.1% YTD) and SG&A (excluding depreciation and amortization) falling 18.4% (+5.7% year-to-date).  In terms of costs, we no longer faced the tough comp from Q2 2013 and commodity hedges helped offset currency hedge headwinds.  As for SG&A, phasing of commercial spend, lower variable compensation accruals and “non-working money” initiatives were the primary factors behind the results.

 

CSD&Nanc Brazil results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

7,423.9

   

(151.7)

7,272.2

-2.0%

-2.0%

Net revenue

831.9

   

44.7

876.6

5.4%

5.4%

Net revenue/hl

112.1

   

8.5

120.5

7.6%

7.6%

COGS

(348.6)

   

(27.1)

(375.7)

7.8%

7.8%

COGS/hl

(47.0)

   

(4.7)

(51.7)

10.0%

10.0%

Gross profit

483.2

   

17.6

500.9

3.6%

3.6%

Gross margin

58.1%

   

 

57.1%

-100 bps

-100 bps

SG&A excl. deprec.&amort.

(173.6)

   

32.0

(141.6)

-18.4%

-18.4%

SG&A deprec.&amort.

(26.3)

   

(2.3)

(28.6)

8.8%

8.8%

SG&A total

(199.9)

   

29.6

(170.3)

-14.8%

-14.8%

Other operating income

84.4

   

0.8

85.2

0.9%

0.9%

Normalized EBIT

367.8

   

48.1

415.8

13.1%

13.1%

Normalized EBIT margin

44.2%

   

 

47.4%

320 bps

320 bps

Normalized EBITDA

424.5

   

48.2

472.7

11.3%

11.3%

Normalized EBITDA margin

51.0%

   

 

53.9%

290 bps

290 bps

 

CSD&Nanc Brazil results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

21,673.6

   

(519.4)

21,154.3

-2.4%

-2.4%

Net revenue

2,351.1

   

132.3

2,483.3

5.6%

5.6%

Net revenue/hl

108.5

   

8.9

117.4

8.2%

8.2%

COGS

(1,017.2)

   

(115.4)

(1,132.6)

11.3%

11.3%

COGS/hl

(46.9)

   

(6.6)

(53.5)

14.1%

14.1%

Gross profit

1,333.9

   

16.9

1,350.8

1.3%

1.3%

Gross margin

56.7%

   

 

54.4%

-230 bps

-230 bps

SG&A excl. deprec.&amort.

(473.4)

   

(27.1)

(500.5)

5.7%

5.7%

SG&A deprec.&amort.

(77.1)

   

(9.4)

(86.5)

12.2%

12.2%

SG&A total

(550.5)

   

(36.5)

(587.0)

6.6%

6.6%

Other operating income

158.6

   

44.0

202.6

27.8%

27.8%

Normalized EBIT

942.0

   

24.4

966.3

2.6%

2.6%

Normalized EBIT margin

40.1%

   

 

38.9%

-120 bps

-120 bps

Normalized EBITDA

1,110.5

   

35.9

1,146.4

3.2%

3.2%

Normalized EBITDA margin

47.2%

   

 

46.2%

-100 bps

-100 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 2  

 

 

  HILA-ex

Our operations in HILA-ex delivered an EBITDA of R$ 121.8 million (+37.5%).  EBITDA margin expanded 630 bps to 32.2%.  Thru September 30, 2013, HILA-ex generated R$ 283.6 million of EBITDA (+42.2%), with an EBITDA margin of 29.4% (+530 bps).

This was another quarter of improvement for HILA-ex: our business in the Dominican Republic delivered strong top line growth despite the challenging industry environment, our Guatemalan operations continued to deliver consistent volume and market share growth, and our plans for further expanding into other islands in the Caribbean remains on track.  NR/Hl grew 10.9%, COGS per hectoliter rose 10.1%, while SG&A (excluding depreciation and amortization) declined 10.5%. 

 

HILA-Ex results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume total ('000 hl)

1,590.0

 

 

(2.7)

1,587.3

-0.2%

-0.2%

Beer volume ('000 hl)

1,194.0

 

 

12.4

1,206.4

1.0%

1.0%

CSD volume ('000 hl)

396.0

 

 

(15.1)

380.9

-3.8%

-3.8%

Net revenue

316.1

8.5

19.4

33.9

377.9

19.5%

10.7%

Net revenue/hl

198.8

5.3

12.2

21.7

238.1

19.7%

10.9%

COGS

(149.7)

(3.2)

(9.9)

(14.8)

(177.6)

18.6%

9.9%

COGS/hl

(94.1)

(2.0)

(6.2)

(9.5)

(111.9)

18.8%

10.1%

Gross profit

166.4

5.3

9.5

19.1

200.3

20.3%

11.5%

Gross margin

52.6%

 

 

 

53.0%

40 bps

40 bps

SG&A excl. deprec.&amort.

(110.0)

(2.1)

(6.2)

11.6

(106.6)

-3.1%

-10.5%

SG&A deprec.&amort.

(11.5)

(0.2)

(0.6)

2.4

(9.9)

-13.4%

-20.7%

SG&A total

(121.5)

(2.3)

(6.8)

14.0

(116.6)

-4.0%

-11.5%

Other operating income/expenses

(0.2)

(0.1)

(0.1)

(1.1)

(1.5)

nm

nm

Normalized EBIT

44.8

2.9

2.6

31.9

82.2

83.7%

71.3%

Normalized EBIT margin

14.2%

 

 

 

21.8%

760 bps

770 bps

Normalized EBITDA

82.2

3.9

4.9

30.8

121.8

48.2%

37.5%

Normalized EBITDA margin

26.0%

 

 

 

32.2%

620 bps

630 bps

 

HILA-Ex results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume total ('000 hl)

3,355.1

780.5

 

68.5

4,204.1

25.3%

2.0%

Beer volume ('000 hl)

2,430.8

724.2

 

87.6

3,242.6

33.4%

3.6%

CSD volume ('000 hl)

924.3

56.4

 

(19.1)

961.6

4.0%

-2.1%

Net revenue

594.7

275.4

37.9

57.9

965.9

62.4%

9.7%

Net revenue/hl

177.3

33.1

9.0

10.3

229.8

29.6%

5.8%

COGS

(305.1)

(103.1)

(20.4)

(25.3)

(453.9)

48.8%

8.3%

COGS/hl

(90.9)

(7.8)

(4.9)

(4.4)

(108.0)

18.7%

4.8%

Gross profit

289.6

172.3

17.5

32.6

512.0

76.8%

11.3%

Gross margin

48.7%

 

 

 

53.0%

430 bps

70 bps

SG&A excl. deprec.&amort.

(231.6)

(67.0)

(13.3)

13.4

(298.5)

28.9%

-5.8%

SG&A deprec.&amort.

(24.2)

(7.2)

(1.3)

(0.5)

(33.3)

37.3%

2.0%

SG&A total

(255.9)

(74.2)

(14.6)

12.9

(331.8)

29.7%

-5.0%

Other operating income/expenses

1.2

(4.1)

0.0

(0.9)

(3.8)

nm

-80.5%

Normalized EBIT

35.0

94.0

2.9

44.5

176.4

nm

127.4%

Normalized EBIT margin

5.9%

 

 

 

18.3%

nm

630 bps

Normalized EBITDA

105.7

126.4

6.9

44.7

283.6

168.3%

42.2%

Normalized EBITDA margin

17.8%

 

 

 

29.4%

nm

530 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 3  

 

 

  Latin America South (LAS)

As from January 1, 2013 our LAS region includes the operations for Argentina, Bolivia, Paraguay, Uruguay, Chile, Peru and Ecuador. 

We delivered R$ 674.8 million of Normalized EBITDA for LAS (+20.3%), with EBITDA margin expanding 190 bps to 41.5%.  Thru September 30, 2013, EBITDA margin was up 60 bps, with a total EBITDA of R$ 1,916.4 million (+14.6%).

Net revenues for LAS improved +14.8%, continuing to benefit from better volume performance as compared to the first half of the year (Q3 2013: -0.3% vs. H1 2013: -6.4%) thanks to a lower rate of decline for LAS Beer (-2.0% vs. -5.3% in H1 2013) and LAS CSD & NANC back to growth (+2.2%).  Meanwhile, NR/Hl strategy in the region continued to deliver strong results, growing 15.1% (LAS Beer: +17.0%; LAS CSD & NANC: +12.7%).

COGS/Hl for LAS rose 13.5% driven primarily by higher packaging and labor-related costs, while SG&A (excluding depreciation and amortization) increased by 7.8% mainly as a result of higher distribution expenses (freight and labor) in Argentina, partially offset by phasing of sales and marketing expenses.

 

LAS results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

8,192.2

 

-

(25.1)

8,167.1

-0.3%

-0.3%

Net revenue

1,418.6

 

(1.0)

209.5

1,627.1

14.7%

14.8%

Net revenue/hl

173.2

 

(0.1)

26.2

199.2

15.1%

15.1%

COGS

(579.5)

 

(0.1)

(76.4)

(656.0)

13.2%

13.2%

COGS/hl

(70.7)

 

(0.0)

(9.6)

(80.3)

13.5%

13.5%

Gross profit

839.1

 

(1.1)

133.1

971.1

15.7%

15.9%

Gross margin

59.1%

 

 

 

59.7%

60 bps

60 bps

SG&A excl. deprec.&amort.

(346.9)

 

(0.8)

(27.1)

(374.8)

8.1%

7.8%

SG&A deprec.&amort.

(30.8)

 

0.8

(2.7)

(32.7)

6.1%

8.7%

SG&A total

(377.7)

 

(0.0)

(29.8)

(407.5)

7.9%

7.9%

Other operating income/expenses

8.5

-

1.6

(10.6)

(0.5)

-106.1%

-124.6%

Normalized EBIT

469.9

 

0.5

92.7

563.1

19.8%

19.7%

Normalized EBIT margin

33.1%

 

 

 

34.6%

150 bps

150 bps

Normalized EBITDA

559.3

 

2.1

113.5

674.8

20.7%

20.3%

Normalized EBITDA margin

39.4%

-

 

 

41.5%

210 bps

190 bps

 

LAS results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

26,748.8

 

 

(1,208.7)

25,540.0

-4.5%

-4.5%

Net revenue

4,124.6

 

59.3

526.0

4,709.9

14.2%

12.8%

Net revenue/hl

154.2

 

2.3

27.9

184.4

19.6%

18.1%

COGS

(1,690.6)

 

(29.9)

(156.9)

(1,877.3)

11.0%

9.3%

COGS/hl

(63.2)

 

(1.2)

(9.1)

(73.5)

16.3%

14.4%

Gross profit

2,434.0

 

29.4

369.2

2,832.6

16.4%

15.2%

Gross margin

59.0%

 

 

 

60.1%

110 bps

130 bps

SG&A excl. deprec.&amort.

(960.7)

 

(18.9)

(137.1)

(1,116.7)

16.2%

14.3%

SG&A deprec.&amort.

(77.5)

 

(0.2)

(3.9)

(81.6)

5.3%

5.1%

SG&A total

(1,038.2)

 

(19.1)

(141.0)

(1,198.3)

15.4%

13.6%

Other operating income/expenses

(4.4)

 

5.4

(21.6)

(20.6)

nm

nm

Normalized EBIT

1,391.4

 

15.6

206.6

1,613.7

16.0%

14.8%

Normalized EBIT margin

33.7%

 

 

 

34.3%

60 bps

70 bps

Normalized EBITDA

1,652.6

 

23.1

240.7

1,916.4

16.0%

14.6%

Normalized EBITDA margin

40.1%

 

 

 

40.7%

60 bps

60 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 4  

 

 

  LAS Beer

Our LAS Beer division delivered an EBITDA of R$ 608.7 million (+19.0%) for the quarter, with EBITDA margin expanding 190 bps to arrive at 52.0%. Year-to-date, EBITDA reached R$ 1,731.8 million (+15.2%) and EBITDA margin corresponded to 51.0% (+40 bps).

Net revenue performance in LAS remained strong and grew 14.6% during the quarter, with YoY volumes trending better than H1 2013 (-2.0% vs. -5.3% during the first half) while NR/Hl increased 17.0%.  In Argentina, despite the challenging environment, volumes were slightly up as we still benefited from easy comps and posted market share gains thanks to the continued success of our innovation in the country around Quilmes and Stella Artois.

As for costs and expenses, COGS/Hl was up 15.6% due mostly to higher packaging and labor-related costs, and SG&A (excluding depreciation and amortization) expenses increased 7.0%, with higher labor costs and freight expenses in Argentina which were partially offset by phasing of sales and marketing spend.

 

LAS Beer

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

4,853.7

 

 

(97.1)

4,756.7

-2.0%

-2.0%

Net revenue

1,008.1

 

15.8

147.5

1,171.4

16.2%

14.6%

Net revenue/hl

207.7

 

3.3

35.2

246.3

18.6%

17.0%

COGS

(330.8)

 

(8.0)

(44.0)

(382.8)

15.7%

13.3%

COGS/hl

(68.2)

 

(1.7)

(10.6)

(80.5)

18.1%

15.6%

Gross profit

677.2

 

7.9

103.5

788.6

16.4%

15.3%

Gross margin

67.2%

 

 

 

67.3%

10 bps

40 bps

SG&A excl. deprec.&amort.

(230.3)

 

(3.2)

(16.0)

(249.4)

8.3%

7.0%

SG&A deprec.&amort.

(17.5)

 

0.3

(7.8)

(25.0)

42.9%

44.7%

SG&A total

(247.7)

 

(2.8)

(23.8)

(274.4)

10.8%

9.6%

Other operating income/expenses

6.7

 

1.4

(5.2)

3.0

-56.0%

-76.6%

Normalized EBIT

436.3

 

6.4

74.5

517.2

18.5%

17.1%

Normalized EBIT margin

43.3%

 

 

 

44.1%

80 bps

90 bps

Normalized EBITDA

505.7

 

6.7

96.2

608.7

20.4%

19.0%

Normalized EBITDA margin

50.2%

 

 

 

52.0%

180 bps

190 bps

 

LAS Beer

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

15,695.4

 

 

(676.6)

15,018.8

-4.3%

-4.3%

Net revenue

2,898.0

 

82.1

412.6

3,392.7

17.1%

14.2%

Net revenue/hl

184.6

 

5.5

35.8

225.9

22.3%

19.4%

COGS

(930.3)

 

(39.6)

(111.8)

(1,081.6)

16.3%

12.0%

COGS/hl

(59.3)

 

(2.6)

(10.1)

(72.0)

21.5%

17.1%

Gross profit

1,967.7

 

42.6

300.8

2,311.1

17.5%

15.3%

Gross margin

67.9%

 

 

 

68.1%

20 bps

60 bps

SG&A excl. deprec.&amort.

(642.4)

 

(20.6)

(88.8)

(751.7)

17.0%

13.8%

SG&A deprec.&amort.

(43.4)

 

(0.6)

(8.5)

(52.6)

21.1%

19.6%

SG&A total

(685.8)

 

(21.2)

(97.3)

(804.3)

17.3%

14.2%

Other operating income/expenses

(7.8)

 

4.8

(10.9)

(13.9)

78.2%

139.9%

Normalized EBIT

1,274.1

 

26.2

192.6

1,492.9

17.2%

15.1%

Normalized EBIT margin

44.0%

 

 

 

44.0%

bps

30 bps

Normalized EBITDA

1,474.1

 

33.8

223.9

1,731.8

17.5%

15.2%

Normalized EBITDA margin

50.9%

 

 

 

51.0%

10 bps

40 bps

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 5  

 

 

  LAS CSD & NANC

EBITDA for LAS CSD & NANC reached R$ 66.2 million in Q3 2013 (+32.1%) and EBITDA margin expanded 190 bps.  For the first nine months of the year, the division delivered an EBITDA of R$ 184.5 million (+9.4%) with flat EBITDA margin.

Volumes for CSD & NANC were up 2.2% as we cycled easy comps from Q3 2012, and the top line was further supported by 12.7% NR/Hl growth, giving us +15.1% net revenue growth for the quarter.  On the brands side, innovation around H2Oh! and Paso de los Toros in Argentina performed best.

COGS/Hl increased 10.6% and SG&A (excluding depreciation and amortization) grew 10.0%, mainly impacted by higher labor costs and greater freight expenses in Argentina.

 

LAS CSD&Nanc

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

3,338.5

 

 

72.0

3,410.5

2.2%

2.2%

Net revenue

410.5

 

(16.9)

62.1

455.7

11.0%

15.1%

Net revenue/hl

123.0

 

(5.0)

15.6

133.6

8.7%

12.7%

COGS

(248.7)

 

7.8

(32.4)

(273.2)

9.9%

13.0%

COGS/hl

(74.5)

 

2.3

(7.9)

(80.1)

7.5%

10.6%

Gross profit

161.8

 

(9.0)

29.7

182.5

12.8%

18.4%

Gross margin

39.4%

 

 

 

40.1%

70 bps

110 bps

SG&A excl. deprec.&amort.

(116.6)

 

2.9

(11.6)

(125.4)

7.5%

10.0%

SG&A deprec.&amort.

(13.3)

 

0.6

5.0

(7.7)

-42.1%

-37.7%

SG&A total

(130.0)

 

3.4

(6.6)

(133.1)

2.4%

5.1%

Other operating income/expenses

1.8

 

0.2

(5.5)

(3.5)

nm

nm

Normalized EBIT

33.7

 

(5.4)

17.6

45.9

36.5%

52.4%

Normalized EBIT margin

8.2%

 

 

 

10.1%

190 bps

270 bps

Normalized EBITDA

53.6

 

(4.6)

17.2

66.2

23.5%

32.1%

Normalized EBITDA margin

13.1%

 

 

 

14.5%

140 bps

190 bps

 

LAS CSD&Nanc

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

11,053.4

 

 

(532.2)

10,521.2

-4.8%

-4.8%

Net revenue

1,226.6

 

(22.8)

113.5

1,317.2

7.4%

9.2%

Net revenue/hl

111.0

 

(2.2)

16.4

125.2

12.8%

14.8%

COGS

(760.3)

 

9.7

(45.1)

(795.7)

4.7%

5.9%

COGS/hl

(68.8)

 

0.9

(7.8)

(75.6)

10.0%

11.3%

Gross profit

466.3

 

(13.2)

68.4

521.5

11.8%

14.7%

Gross margin

38.0%

 

 

 

39.6%

160 bps

190 bps

SG&A excl. deprec.&amort.

(318.3)

 

1.6

(48.3)

(365.0)

14.7%

15.2%

SG&A deprec.&amort.

(34.1)

 

0.4

4.6

(29.1)

-14.7%

-13.4%

SG&A total

(352.4)

 

2.1

(43.7)

(394.0)

11.8%

12.4%

Other operating income/expenses

3.4

 

0.5

(10.6)

(6.7)

nm

nm

Normalized EBIT

117.3

 

(10.5)

14.0

120.8

3.0%

11.9%

Normalized EBIT margin

9.6%

 

 

 

9.2%

-40 bps

20 bps

Normalized EBITDA

178.5

 

(10.7)

16.7

184.5

3.4%

9.4%

Normalized EBITDA margin

14.6%

 

 

 

14.0%

-60 bps

bps

 

 

  

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 6  

 

 

  Canada

In Canada we delivered a Normalized EBITDA of R$ 582.0 million (+0.6%) during Q3 2013, with an EBITDA margin expansion of 30 bps to 46.6%.  Year-to-date, Labatt’s Normalized EBITDA totalled R$ 1,315.5 million (-2.0%) with an EBITDA margin of 41.3% (-30 bps). 

In terms of the top line, the Canadian beer industry remained under pressure, albeit by less than what we experienced in the first six months of the year.  Accordingly, we estimate that industry volumes declined 1.2% due to cooler weather and higher taxes in Quebec implemented late 2012.  Market share was sequentially flat (-20 bps vs. Q3 2012), but net revenue per hectoliter continued to show good growth (+2.2%).  Market share performance was positively impacted by innovation, such as the launch of Budweiser Black Crown in August, but also by sustained improvements in Bud Light Platinum and Bud Lime Lime-a-Rita.   

In terms of costs and expenses, COGS per hectoliter increased 1.5% (well below H1 2013’s mid-single digit growth YoY), benefitting from our commodity hedges.  Meanwhile, SG&A (excluding depreciation and amortization) results were also better than the first half, increasing 1.9% in the quarter thanks mostly to phasing of sales and marketing spend.

 

Canada results

3Q12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

3Q13

Reported

Organic

Volume ('000 hl)

2,664.2

 

 

(59.8)

2,604.4

-2.2%

-2.2%

Net revenue

1,170.1

(18.1)

98.4

(1.3)

1,249.1

6.7%

-0.1%

Net revenue/hl

439.2

(6.8)

37.8

9.4

479.6

9.2%

2.2%

COGS

(332.2)

 

(28.4)

2.5

(358.1)

7.8%

-0.8%

COGS/hl

(124.7)

 

(10.9)

(1.9)

(137.5)

10.3%

1.5%

Gross profit

837.9

(18.1)

69.9

1.2

891.0

6.3%

0.1%

Gross margin

71.6%

 

 

 

71.3%

-30 bps

20 bps

SG&A excl. deprec.&amort.

(330.3)

18.1

(27.3)

(5.8)

(345.2)

4.5%

1.9%

SG&A deprec.&amort.

(13.0)

 

(1.1)

0.4

(13.7)

5.8%

-2.9%

SG&A total

(343.2)

18.1

(28.4)

(5.4)

(359.0)

4.6%

1.7%

Other operating income/expenses

0.7

 

0.3

4.6

5.5

nm

nm

Normalized EBIT

495.4

 

41.8

0.3

537.5

8.5%

0.1%

Normalized EBIT margin

42.3%

 

 

 

43.0%

70 bps

10 bps

Normalized EBITDA

533.8

 

45.0

3.2

582.0

9.0%

0.6%

Normalized EBITDA margin

45.6%

 

 

 

46.6%

100 bps

30 bps

 

Canada results

YTD12 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

YTD13

Reported

Organic

Volume ('000 hl)

7,170.8

 

 

(216.3)

6,954.5

-3.0%

-3.0%

Net revenue

2,999.4

(45.8)

264.6

(34.2)

3,184.0

6.2%

-1.2%

Net revenue/hl

418.3

(6.4)

38.0

7.9

457.8

9.5%

1.9%

COGS

(843.0)

 

(75.5)

(3.4)

(922.0)

9.4%

0.4%

COGS/hl

(117.6)

 

(10.9)

(4.1)

(132.6)

12.8%

3.5%

Gross profit

2,156.4

(45.8)

189.0

(37.6)

2,262.0

4.9%

-1.8%

Gross margin

71.9%

 

 

 

71.0%

-90 bps

-50 bps

SG&A excl. deprec.&amort.

(995.3)

45.8

(88.0)

8.7

(1,028.8)

3.4%

-0.9%

SG&A deprec.&amort.

(33.8)

 

(3.1)

(0.5)

(37.3)

10.5%

1.4%

SG&A total

(1,029.1)

45.8

(91.0)

8.2

(1,066.1)

3.6%

-0.8%

Other operating income/expenses

5.2

 

0.5

(0.4)

5.4

2.5%

-7.9%

Normalized EBIT

1,132.6

 

98.6

(29.8)

1,201.3

6.1%

-2.6%

Normalized EBIT margin

37.8%

 

 

 

37.7%

-10 bps

-50 bps

Normalized EBITDA

1,232.0

 

107.8

(24.3)

1,315.5

6.8%

-2.0%

Normalized EBITDA margin

41.1%

 

 

 

41.3%

20 bps

-30 bps

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 7  

 

 

 Other operating income/(expense)

Other operating income grew R$ 143 million in Q3 2013, totalling R$ 394.3 million.  This result was caused by another quarter of higher government grants related to State VAT long-term tax incentives as a consequence of the higher level of capital expenditure investments in Brazil, as well as one-off gains associated with certain legal proceedings.

  

Other operating income/(expenses)

3Q12 Reference Base

3Q13

YTD12 Reference Base

YTD13

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

Government grants/NPV of long term fiscal incentives

209.6

251.0

476.2

804.8

(Additions to)/reversals of provisions

(12.8)

(15.7)

(24.6)

(17.0)

Net gain on disposal of property, plant and equipment and intangible assets

11.0

14.6

7.0

17.1

Net other operating income

44.1

144.4

101.7

197.6

 

 

 

 

 

 

251.9

394.3

560.3

1,002.6

 

 

 

 

  Special items

 

During the third quarter we recorded an expense of R$ 6.9 million in special items (as compared to R$ 9.6 million in 3Q 2012) in connection with restructuring costs.  Year-to-date, special items resulted in an expense of R$ 13.2 million (vs. R$ 36.4 million in Q3 2012).

 

 

 

Special items

3Q12 Reference Base

3Q13

YTD12 Reference Base

YTD13

 

   

 

 

R$ million

   

 

 

 

   

 

 

Restructuring

(9.6)

(6.9)

(17.3)

(13.2)

Acquisition of subsidiaries

 

 

(15.8)

 

Other special items

 

 

(3.3)

 

 

 

 

 

 

 

(9.6)

(6.9)

(36.4)

(13.2)

 

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 8  

 

 

 Net finance results

Net finance results totalled an expense of R$ 496.1 million, which was R$ 129.3 million higher than Q3 2012.  This performance resulted predominantly from losses on non-derivative instruments, which were only partially offset by higher interest income and lower losses on derivative instruments.

 

 

Net finance results

3Q12 Reference Base

3Q13

YTD12 Reference Base

YTD13

 

R$ million

 

     

 

 

 

 

 

Interest income

47.4

70.7

192.2

211.0

 

 

Interest expenses

(121.0)

(136.2)

(278.6)

(385.7)

 

 

Gains/(losses) on derivative instruments

(106.4)

(49.3)

(138.4)

(203.0)

 

 

Gains/(losses) on non-derivative instruments

(75.8)

(260.1)

(96.5)

(273.6)

 

 

Taxes on financial transactions

(14.5)

(23.0)

(89.5)

(65.4)

 

 

Interest on defined benefit liabilities

(22.6)

(22.9)

(62.7)

(65.7)

 

 

Other financial income/(expenses), net

(74.1)

(75.3)

(161.7)

(222.6)

 

     

 

 

 

 

Net finance results

(366.8)

(496.1)

(635.3)

(1,005.0)

 

 

As of September 30, 2013 we held a net cash position of R$ 2,399.7 million (down from R$ 6,258.9 million as of December 31, 2012).  Consolidated debt corresponded to R$ 2,999.7 million (a decrease of R$ 144.0 million since December 2012) whereas cash and cash equivalents totalled R$ 4,787.9 million, down from R$ 8,926.2 million at the end of 2012.

 

 

 

December 2012

September 13

 

Debt Breakdown

Current

Non-current

Total

Current

Non-current

Total

 

       

 

 

 

 

Local Currency

667.4

1,756.4

2,423.8

612.9

1,374.8

1,987.8

 

Foreign Currency

170.4

549.6

720.0

284.9

727.0

1,011.9

 

Consolidated Debt

837.8

2,306.0

3,143.7

897.9

2,101.8

2,999.7

 

       

 

 

 

 

Cash and Cash Equivalents

   

8,926.2

 

 

4,787.9

 

Current Investment Securities

   

476.6

 

 

612.5

 

Bank overdrafts

   

(0.1)

 

 

(0.9)

 

       

 

 

 

 

Net Debt/ (Cash)

   

(6,258.9)

 

 

(2,399.7)

 

 

 

 

 

 

 

 

 

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page 1 9  

 

 

 Provision for income tax & social contribution

The weighted nominal tax rate for the quarter was 33.4% versus 32.0% in Q3 2012.  Our effective tax rate was 26.7% (versus the tough comp of 15.2% in the third quarter of 2012), impacted mostly by the lack of interest on capital during the quarter  and an additional accrued expense of approximately R$ 135 million due to the new 10% withholding tax on Argentinean earnings.

The table below shows the reconciliation for income tax and social contribution provision.

 

 

 

 

3Q12 Reference Base

3Q13

YTD12 Reference Base

YTD13

 

Income tax and social contribution

 

R$ million

 

     

 

 

 

 

Profit before tax

2,949.9

3,184.4

8,184.7

8,518.5

 

     

 

 

 

 

Adjustment on taxable basis

 

 

 

 

 

 

Non-taxable net financial and other income

(113.7)

(57.7)

(347.5)

(243.5)

 

 

Goverment grants (VAT)

(173.2)

(190.7)

(369.1)

(531.6)

 

 

Share of results of associates

(0.0)

(3.9)

(0.1)

(5.7)

 

 

Expenses not deductible for tax purposes

107.3

39.7

155.6

177.8

 

   

2,770.2

2,971.9

7,623.5

7,915.5

 

 

Aggregated weighted nominal tax rate

32.0%

33.4%

32.2%

32.7%

 

 

Taxes – nominal rate

(887.6)

(991.1)

(2,456.3)

(2,588.8)

 

     

 

 

 

 

Adjustment on tax expense

 

 

 

 

 

 

Tax benefit - interest on shareholders' equity

127.4

0.0

400.4

124.6

 

 

Tax benefit - amortization on tax books

30.2

62.6

90.6

187.8

 

 

Other tax adjustments

281.8

79.5

545.9

393.1

 

 

Income tax and social contribution expense

(448.2)

(848.9)

(1,419.4)

(1,883.2)

 

 

Effective tax rate

15.2%

26.7%

17.3%

22.1%

 

 

 

 

 

 

 

 

 

 Shareholding structure

The table below summarizes Ambev S.A.’s shareholding structure as of September 30, 2013.

 

Ambev S.A.'s shareholding structure

 

ON

%Outs

Anheuser-Busch InBev

9,693,646,325

61.9%

FAHZ

1,501,432,405

9.6%

Market

4,466,357,390

28.5%

Outstanding

15,661,436,120

100.0%

Treasury

0

 

TOTAL

15,661,436,120

 

Free float BM&FBovespa

3,018,573,430

19.3%

Free float NYSE

1,447,783,960

9.2%

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  20  

 

 

 Reconciliation between normalized EBITDA & profit

Both Normalized EBITDA and EBIT are measures used by Ambev’s management to measure the Company’s performance. 

Normalized EBITDA is calculated excluding from Profit the following effects: (i) Non-controlling interest, (ii) Income Tax expense, (iii) Share of results of associates, (iv) Net finance results, (v) Special items, and (vi) Depreciation & Amortization.  

Normalized EBITDA and EBIT are not accounting measures under accounting practices in Brazil, IFRS or the United States of America (US GAAP) and should not be considered as an alternative to Profit as a measure of operational performance or an alternative to Cash Flow as a measure of liquidity.  Normalized EBITDA and EBIT do not have a standard calculation method and Ambev’s definition of Normalized EBITDA and EBIT may not be comparable to that of other companies.

 

 

Reconciliation - Profit to EBITDA

3Q12 Reference Base

3Q13

YTD12 Reference Base

YTD13

Profit - Ambev holders

2,476.9

2,280.3

6,695.0

6,506.2

Non-controlling interest

24.8

55.2

70.3

129.0

Income tax expense

448.2

848.9

1,419.4

1,883.2

Profit before taxes

2,949.9

3,184.4

8,184.7

8,518.5

Share of results of associates

(0.0) 

(3.9)

(0.1)

(5.7)

Net finance results

366.8

496.1

635.3

1,005.0

Special items

9.6

6.9

36.4

13.2

Normalized EBIT

3,326.3

3,683.6

8,856.3

9,531.0

Depreciation & amortization - total

461.1

515.7

1,268.1

1,485.2

Normalized EBITDA

3,787.4

4,199.3

10,124.4

11,016.2

 

                   

      

  Revised IAS 19 and 2012 Reference Base

The revised IFRS standard “IAS 19 Employee Benefits” was effective from January 1, 2013.  Therefore, we are presenting the net pension interest cost as part of the net finance costs and have provided the restated figures per division for 2012, as if the revised standard had been effective as from January 1, 2012.

In addition, the 2012 Reference Base also reflects the transfer of management responsibility for Ecuador and Peru to the Latin America South division, as previously mentioned.

 

 

 

 

In connection with the Stock Swap Merger, on June 28, 2013 Ambev S.A. filed with the U.S. Securities and Exchange Commission (the “ Commission ”) a registration statement on Form F-4 that contains a prospectus, which may be subject to change. Investors and security holders of Companhia de Bebidas das Américas – Ambev are urged to read these materials and the definitive versions thereof, as well as any other relevant documents filed with the Commission as they become available, because they contain and will contain important information about Ambev S.A. , Companhia de Bebidas das Américas – Ambev and the Stock Swap Merger. The prospectus filed with the Commission on June 28, 2013 as part of the registration statement, the definitive version of the prospectus and other relevant materials (when they become available), and any other documents filed by Ambev S.A. with the Commission, may be obtained free of charge at the Commission’s website at www.sec.gov  or from Ambev

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  21  

 

  

 Q 3 2013 Earnings Conference Call

 

Speakers:

João Castro Neves

Chief Executive Officer

 

Nelson Jamel

Chief Financial and Investor Relations Officer

 

 

 

Language:

English

 

 

 

 

Date:

October 31, 2013 (Thursday)

 

 

 

 

Time:

13:00 (Brasília time)

11:00 (EST)

 

 

 

 

Phone number:

US participants

+ 1(877) 317-6776

 

International participants

+ 1(412) 317-6776

 

 

 

Code:

Ambev

 

 

Please call 15 minutes prior to the beginning of the conference call.

Webcast: The conference call will also be transmitted live through the Internet, available on Ambev’s website: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1732 

Playback: The conference call replay through internet will be available one hour after conclusion at Ambev’s website at the same link above. For Playback through telephone: Participants calling from USA: +1(877) 344-7529 / Participants calling from other countries: +1(412) 317-0088 / Code: 10035435# (pound key) - enter "1" to start the playback.

  

For additional information, please contact the Investor Relations team:

 

Lucas Lira

(+55 11) 2122-1415
lucas.lira@ambev.com.br

 

Fernando Robbi
(+55 11) 2122-1414
fernando.robbi@ambev.com.br

 

www.ambev-ir.com

 

 

 

Statements contained in this press release may contain information that is forward-looking and reflects management’s current view and estimates of future economic circumstances, industry conditions, company performance, and finance results. Any statements, expectations, capabilities, plans and assumptions contained in this press release that do not describe historical facts, such as statements regarding the declaration or payment of dividends, the direction of future operations, the implementation of principal operating and financing strategies and capital expenditure plans, the factors or trends affecting financial condition, liquidity or results of operations, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. There is no guarantee that these results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

 

.


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  22  

 

 

Ambev - Segment financial information

 

 

 

 

 

Organic results

 

 

 

 

 

 

Ambev Brazil

Hila Operations

Canada

Ambev

 

Beer Brazil

CSD & NANC Brazil

Total Ambev Brazil

LAS

Hila-ex

Operations

Consolidated

 

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

3Q12 Reference Base

3Q13

%

Volumes (000 hl)

20,660

19,635

-5.0%

7,424

7,272

-2.0%

28,084

26,907

-4.2%

8,192

8,167

-0.3%

1,590

1,587

-0.2%

2,664

2,604

-2.2%

40,530

39,266

-3.1%

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

4,299.3

4,331.9

0.8%

831.9

876.6

5.4%

5,131.2

5,208.5

1.5%

1,418.6

1,627.1

14.8%

316.1

377.9

10.7%

1,170.1

1,249.1

-0.1%

8,036.0

8,462.6

4.0%

% of total

53.5%

51.2%

 

10.4%

10.4%

 

63.9%

61.5%

 

17.7%

19.2%

 

3.9%

4.5%

 

14.6%

14.8%

 

100.0%

100.0%

 

COGS

(1,211.4)

(1,248.8)

3.1%

(348.6)

(375.7)

7.8%

(1,560.0)

(1,624.5)

4.1%

(579.5)

(656.0)

13.2%

(149.7)

(177.6)

9.9%

(332.2)

(358.1)

-0.8%

(2,621.5)

(2,816.2)

5.8%

% of total

46.2%

44.3%

 

13.3%

13.3%

 

59.5%

57.7%

 

22.1%

23.3%

 

5.7%

6.3%

 

12.7%

12.7%

 

100.0%

100.0%

 

Gross profit

3,087.9

3,083.1

-0.2%

483.2

500.9

3.6%

3,571.1

3,584.0

0.4%

839.1

971.1

15.9%

166.4

200.3

11.5%

837.9

891.0

0.1%

5,414.6

5,646.4

3.1%

% of total

57.0%

54.6%

 

8.9%

8.9%

 

66.0%

63.5%

 

15.5%

17.2%

 

3.1%

3.5%

 

15.5%

15.8%

 

100.0%

100.0%

 

SG&A

(1,297.8)

(1,303.8)

0.5%

(199.9)

(170.3)

-14.8%

(1,497.7)

(1,474.0)

-1.6%

(377.7)

(407.5)

7.9%

(121.5)

(116.6)

-11.5%

(343.2)

(359.0)

1.7%

(2,340.1)

(2,357.1)

-0.1%

% of total

55.5%

55.3%

 

8.5%

7.2%

 

64.0%

62.5%

 

16.1%

17.3%

 

5.2%

4.9%

 

14.7%

15.2%

 

100.0%

100.0%

 

Other operating income/(expenses)

158.4

305.6

92.9%

84.4

85.2

0.9%

242.8

390.8

60.9%

8.5

(0.5)

-124.6%

(0.2)

(1.5)

nm

0.7

5.5

nm

251.9

394.3

55.9%

% of total

62.9%

77.5%

 

33.5%

21.6%

 

96.4%

99.1%

 

3.4%

-0.1%

 

-0.1%

-0.4%

 

0.3%

1.4%

 

100.0%

100.0%

 

Normalized EBIT

1,948.5

2,084.9

7.0%

367.8

415.8

13.1%

2,316.3

2,500.7

8.0%

469.9

563.1

19.7%

44.8

82.2

71.3%

495.4

537.5

0.1%

3,326.3

3,683.6

9.3%

% of total

58.6%

56.6%

 

11.1%

11.3%

 

69.6%

67.9%

 

14.1%

15.3%

 

1.3%

2.2%

 

14.9%

14.6%

 

100.0%

100.0%

 

Normalized EBITDA

2,187.6

2,348.0

7.3%

424.5

472.7

11.3%

2,612.1

2,820.7

8.0%

559.3

674.8

20.3%

82.2

121.8

37.5%

533.8

582.0

0.6%

3,787.4

4,199.3

9.4%

% of total

57.8%

55.9%

 

11.2%

11.3%

 

69.0%

67.2%

 

14.8%

16.1%

 

2.2%

2.9%

 

14.1%

13.9%

 

100.0%

100.0%

 

 

   

 

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

% of net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-28.2%

-28.8%

 

-41.9%

-42.9%

 

-30.4%

-31.2%

 

-40.9%

-40.3%

 

-47.4%

-47.0%

 

-28.4%

-28.7%

 

-32.6%

-33.3%

 

Gross profit

71.8%

71.2%

 

58.1%

57.1%

 

69.6%

68.8%

 

59.1%

59.7%

 

52.6%

53.0%

 

71.6%

71.3%

 

67.4%

66.7%

 

SG&A

-30.2%

-30.1%

 

-24.0%

-19.4%

 

-29.2%

-28.3%

 

-26.6%

-25.0%

 

-38.4%

-30.8%

 

-29.3%

-28.7%

 

-29.1%

-27.9%

 

Other operating income/(expenses)

3.7%

7.1%

 

10.2%

9.7%

 

4.7%

7.5%

 

0.6%

0.0%

 

-0.1%

-0.4%

 

0.1%

0.4%

 

3.1%

4.7%

 

Normalized EBIT

45.3%

48.1%

 

44.2%

47.4%

 

45.1%

48.0%

 

33.1%

34.6%

 

14.2%

21.8%

 

42.3%

43.0%

 

41.4%

43.5%

 

Normalized EBITDA

50.9%

54.2%

 

51.0%

53.9%

 

50.9%

54.2%

 

39.4%

41.5%

 

26.0%

32.2%

 

45.6%

46.6%

 

47.1%

49.6%

 

 

   

 

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

208.1

220.6

6.0%

112.1

120.5

7.6%

182.7

193.6

5.9%

173.2

199.2

15.1%

198.8

238.1

10.9%

439.2

479.6

2.1%

198.3

215.5

7.3%

COGS

(58.6)

(63.6)

8.5%

(47.0)

(51.7)

10.0%

(55.5)

(60.4)

8.7%

(70.7)

(80.3)

13.5%

(94.1)

(111.9)

10.1%

(124.7)

(137.5)

1.5%

(64.7)

(71.7)

9.3%

Gross profit

149.5

157.0

5.1%

65.1

68.9

5.8%

127.2

133.2

4.7%

102.4

118.9

16.2%

104.7

126.2

11.7%

314.5

342.1

2.4%

133.6

143.8

6.4%

SG&A

(62.8)

(66.4)

5.7%

(26.9)

(23.4)

-13.1%

(53.3)

(54.8)

2.7%

(46.1)

(49.9)

8.2%

(76.4)

(73.4)

-11.3%

(128.8)

(137.8)

3.8%

(57.7)

(60.0)

3.1%

Other operating income/(expenses)

7.7

15.6

103.0%

11.4

11.7

3.0%

8.6

14.5

68.0%

1.0

(0.1)

-124.7%

(0.1)

(1.0)

nm

0.3

2.1

nm

6.2

10.0

60.9%

Normalized EBIT

94.3

106.2

12.6%

49.5

57.2

15.4%

82.5

92.9

12.7%

57.4

68.9

20.1%

28.1

51.8

71.6%

185.9

206.4

2.4%

82.1

93.8

12.8%

Normalized EBITDA

105.9

119.6

12.9%

57.2

65.0

13.7%

93.0

104.8

12.7%

68.3

82.6

20.7%

51.7

76.8

37.7%

200.3

223.5

2.9%

93.4

106.9

12.9%

 

 

 

 

.


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  23  

 

 

Ambev - Segment financial information

 

 

 

 

 

 

 

Organic results

 

 

 

 

 

 

 

 

Ambev Brazil

Hila Operations

Canada

Ambev

 

Beer Brazil

CSD & NANC Brazil

Total Ambev Brazil

LAS

Hila-ex

Operations

Consolidated

 

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

YTD12 Reference Base

YTD13

%

Volumes (000 hl)

61,191

58,328

-4.7%

21,674

21,154

-2.4%

82,864

79,482

-4.1%

26,749

25,540

-4.5%

3,355

4,204

2.0%

7,171

6,954

-3.0%

120,139

116,181

-3.9%

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

12,027.4

12,395.4

3.1%

2,351.1

2,483.3

5.6%

14,378.4

14,878.8

3.5%

4,124.6

4,709.9

12.8%

594.7

965.9

9.7%

2,999.4

3,184.0

-1.2%

22,097.1

23,738.5

4.8%

% of total

54.4%

52.2%

 

10.6%

10.5%

 

65.1%

62.7%

 

18.7%

19.8%

 

2.7%

4.1%

 

13.6%

13.4%

 

100.0%

100.0%

 

COGS

(3,378.0)

(3,645.5)

7.9%

(1,017.2)

(1,132.6)

11.3%

(4,395.1)

(4,778.1)

8.7%

(1,690.6)

(1,877.3)

9.3%

(305.1)

(453.9)

8.3%

(843.0)

(922.0)

0.4%

(7,233.8)

(8,031.3)

7.9%

% of total

46.7%

45.4%

 

14.1%

14.1%

 

60.8%

59.5%

 

23.4%

23.4%

 

4.2%

5.7%

 

11.7%

11.5%

 

100.0%

100.0%

 

Gross profit

8,649.4

8,749.9

1.2%

1,333.9

1,350.8

1.3%

9,983.3

10,100.7

1.2%

2,434.0

2,832.6

15.2%

289.6

512.0

11.3%

2,156.4

2,262.0

-1.8%

14,863.3

15,707.2

3.2%

% of total

58.2%

55.7%

 

9.0%

8.6%

 

67.2%

64.3%

 

16.4%

18.0%

 

1.9%

3.3%

 

14.5%

14.4%

 

100.0%

100.0%

 

SG&A

(3,693.7)

(3,995.7)

8.2%

(550.5)

(587.0)

6.6%

(4,244.2)

(4,582.6)

8.0%

(1,038.2)

(1,198.3)

13.6%

(255.9)

(331.8)

-5.0%

(1,029.1)

(1,066.1)

-0.8%

(6,567.3)

(7,178.8)

7.0%

% of total

56.2%

55.7%

 

8.4%

8.2%

 

64.6%

63.8%

 

15.8%

16.7%

 

3.9%

4.6%

 

15.7%

14.9%

 

100.0%

100.0%

 

Other operating income/(expenses)

399.7

819.0

104.9%

158.6

202.6

27.8%

558.3

1,021.6

83.0%

(4.4)

(20.6)

nm

1.2

(3.8)

-80.5%

5.2

5.4

-7.9%

560.3

1,002.6

78.6%

% of total

71.3%

81.7%

 

28.3%

20.2%

 

99.6%

101.9%

 

-0.8%

-2.1%

 

0.2%

-0.4%

 

0.9%

0.5%

 

100.0%

100.0%

 

Normalized EBIT

5,355.4

5,573.3

4.1%

942.0

966.3

2.6%

6,297.4

6,539.6

3.8%

1,391.4

1,613.7

14.8%

35.0

176.4

127.4%

1,132.6

1,201.3

-2.6%

8,856.3

9,531.0

5.2%

% of total

60.5%

58.5%

 

10.6%

10.1%

 

71.1%

68.6%

 

15.7%

16.9%

 

0.4%

1.9%

 

12.8%

12.6%

 

100.0%

100.0%

 

Normalized EBITDA

6,023.6

6,354.3

5.5%

1,110.5

1,146.4

3.2%

7,134.1

7,500.7

5.1%

1,652.6

1,916.4

14.6%

105.7

283.6

42.2%

1,232.0

1,315.5

-2.0%

10,124.4

11,016.2

6.2%

% of total

59.5%

57.7%

 

11.0%

10.4%

 

70.5%

68.1%

 

16.3%

17.4%

 

1.0%

2.6%

 

12.2%

11.9%

 

100.0%

100.0%

 

 

   

 

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

% of net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-28.1%

-29.4%

 

-43.3%

-45.6%

 

-30.6%

-32.1%

 

-41.0%

-39.9%

 

-51.3%

-47.0%

 

-28.1%

-29.0%

 

-32.7%

-33.8%

 

Gross profit

71.9%

70.6%

 

56.7%

54.4%

 

69.4%

67.9%

 

59.0%

60.1%

 

48.7%

53.0%

 

71.9%

71.0%

 

67.3%

66.2%

 

SG&A

-30.7%

-32.2%

 

-23.4%

-23.6%

 

-29.5%

-30.8%

 

-25.2%

-25.4%

 

-43.0%

-34.3%

 

-34.3%

-33.5%

 

-29.7%

-30.2%

 

Other operating income/(expenses)

3.3%

6.6%

 

6.7%

8.2%

 

3.9%

6.9%

 

-0.1%

-0.4%

 

0.2%

-0.4%

 

0.2%

0.2%

 

2.5%

4.2%

 

Normalized EBIT

44.5%

45.0%

 

40.1%

38.9%

 

43.8%

44.0%

 

33.7%

34.3%

 

5.9%

18.3%

 

37.8%

37.7%

 

40.1%

40.1%

 

Normalized EBITDA

50.1%

51.3%

 

47.2%

46.2%

 

49.6%

50.4%

 

40.1%

40.7%

 

17.8%

29.4%

 

41.1%

41.3%

 

45.8%

46.4%

 

 

   

 

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

196.6

212.5

8.1%

108.5

117.4

8.2%

173.5

187.2

7.9%

154.2

184.4

18.1%

177.3

229.8

5.8%

418.3

457.8

1.9%

183.9

204.3

9.0%

COGS

(55.2)

(62.5)

13.2%

(46.9)

(53.5)

14.1%

(53.0)

(60.1)

13.3%

(63.2)

(73.5)

14.4%

(90.9)

(108.0)

4.8%

(117.6)

(132.6)

3.5%

(60.2)

(69.1)

12.2%

Gross profit

141.4

150.0

6.1%

61.5

63.9

3.7%

120.5

127.1

5.5%

91.0

110.9

20.6%

86.3

121.8

6.9%

300.7

325.3

1.2%

123.7

135.2

7.4%

SG&A

(60.4)

(68.5)

13.5%

(25.4)

(27.7)

9.2%

(51.2)

(57.7)

12.6%

(38.8)

(46.9)

19.0%

(76.3)

(78.9)

-5.7%

(143.5)

(153.3)

2.2%

(54.7)

(61.8)

11.3%

Other operating income/(expenses)

6.5

14.0

114.9%

7.3

9.6

30.9%

6.7

12.9

90.8%

(0.2)

(0.8)

nm

0.4

(0.9)

-61.0%

0.7

0.8

-5.1%

4.7

8.6

85.3%

Normalized EBIT

87.5

95.6

9.2%

43.5

45.7

5.1%

76.0

82.3

8.3%

52.0

63.2

20.3%

10.4

42.0

96.8%

157.9

172.7

0.4%

73.7

82.0

9.5%

Normalized EBITDA

98.4

108.9

10.7%

51.2

54.2

5.8%

86.1

94.4

9.6%

61.8

75.0

20.0%

31.5

67.5

30.8%

171.8

189.2

1.1%

84.3

94.8

10.5%

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  24  

 

 

CONSOLIDATED BALANCE SHEET

September 2013

December 12

R$ million

Assets

 

 

Current assets

 

 

Cash and cash equivalents

4,787.9

8,926.2

Investment securities (CURRENT)

612.5

476.6

Trade and other receivables (current)

4,300.4

4,268.2

Inventories

2,586.5

2,466.3

Income tax receivable

100.3

114.5

Assets held for sale

-

4.1

 

12,387.6

16,255.9

Non-current assets

 

 

Investment securities

242.6

249.4

Trade and other receivables

2,086.9

1,855.0

Deferred tax assets

1,718.9

1,418.5

Income tax receivable (non-current)

10.8

12.3

Employee benefits

25.5

25.5

Investments in associates

20.9

24.0

Property, plant and equipment

12,226.4

11,412.3

Intangible assets

3,112.3

2,935.4

Goodwill

19,921.4

19,971.5

 

39,365.7

37,903.8

 

 

 

Total assets

51,753.3

54,159.8

 

 

 

Equity and liabilities

 

 

Current liabilities

 

 

Trade and other payables

8,800.6

13,570.8

Interest-bearing loans and borrowings (current)

897.9

837.8

Bank overdrafts

0.9

0.1

Income tax and social contribution payable

664.4

972.6

Provisions

136.0

137.5

 

10,499.8

15,518.7

Non-current liabilities

 

 

Trade and other payables (NON CURRENT)

3,412.8

3,064.0

Interest-bearing loans and borrowings

2,101.8

2,306.0

Deferred tax liabilities

1,254.7

1,048.3

Provisions (non-CURRENT)

452.1

518.1

Employee benefits (non CURRENT)

1,874.8

1,780.9

 

9,096.2

8,717.3

 

 

 

Total liabilities

19,596.0

24,236.0

 

 

 

Equity

 

 

Issued capital

12,742.0

12,187.3

Reserves

14,408.0

16,676.4

Retained earnings

3,955.6

-

Equity attributable to equity holders of Ambev

31,105.7

28,863.7

Non-controlling interests

1,051.6

1,060.1

Total Equity

32,157.3

29,923.8

 

 

 

Total equity and liabilities

51,753.3

54,159.8

 

.


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  25  

 

 

 

CONSOLIDATED STATEMENT OF OPERATIONS

3Q13

3Q12 Reference Base

YTD13

YTD12 Reference Base

R$ million

 

 

 

 

 

Net sales

8,462.6

8,036.0

23,738.5

22,097.1

Cost of sales

(2,816.2)

(2,621.5)

(8,031.3)

(7,233.8)

Gross profit

5,646.4

5,414.6

15,707.2

14,863.3

 

 

 

 

 

Sales and marketing expenses

(1,999.8)

(1,821.9)

(6,073.3)

(5,375.0)

Administrative expenses

(357.3)

(518.2)

(1,105.5)

(1,192.4)

Other operating income/(expenses)

394.3

251.9

1,002.6

560.3

 

 

 

 

 

Normalized EBIT

3,683.6

3,326.3

9,531.0

8,856.3

 

 

 

 

 

Special items

(6.9)

(9.6)

(13.2)

(36.4)

 

 

 

 

 

Income from operations (EBIT)

3,676.7

3,316.7

9,517.8

8,819.9

 

 

 

 

 

Net finance results

(496.1)

(366.8)

(1,005.0)

(635.3)

Share of results of associates

3.9

0.0

5.7

0.1

 

 

 

 

 

Profit before income tax

3,184.4

2,949.9

8,518.5

8,184.7

 

 

 

 

 

Income tax expense

(848.9)

(448.2)

(1,883.2)

(1,419.4)

 

 

 

 

 

Profit

2,335.5

2,501.7

6,635.3

6,765.3

Attributable to:

 

 

-

-

Equity holders of Ambev

2,280.3

2,476.9

6,506.2

6,695.0

Non-controlling interest

55.2

24.8

129.0

70.3

 

 

 

 

 

Nº of basic shares outstanding

3,128.3

3,121.1

3,128.3

3,122.2

Nº of diluted shares outstanding

3,144.7

3,138.5

3,144.7

3,139.5

 

 

 

 

 

Basic earnings per share (preferred)

0.72

0.84

2.19

2.26

Basic earnings per share (common)

0.65

0.76

1.99

2.05

Diluted earnings per share (preferred)

0.71

0.83

2.18

2.25

Diluted earnings per share (common)

0.65

0.76

1.98

2.04

         

 

 

 


 
 

DESCRIPTION: LOGO_AMBEV_FINAL    

Third Quarter 2013 Results

October 31, 2013

Page  26  

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

3Q13  

3Q12 Reference Base

YTD13

YTD12 Reference Base

 

 

 

 

R$ million

Cash Flows from Operating Activities

 

 

 

 

 

Profit

2,335.5

2,501.7

6,635.3

6,765.3

 

 

Depreciation, amortization and impairment

515.7

461.1

1,485.2

1,268.1

 

 

Impairment losses on receivables and inventories

35.0

40.9

107.6

109.3

 

 

Additions/(reversals) in provisions and employee benefits

52.5

48.0

126.8

153.9

 

 

Net finance cost

496.1

366.8

1,005.0

635.3

 

 

Other non-cash items included in the profit

(63.7)

(42.5)

(137.9)

(151.1)

 

 

Loss/(gain) on sale of property, plant and equipment and intangible assets

(14.6)

(11.0)

(17.1)

(3.7)

 

 

Equity-settled share-based payment expense

39.6

42.8

120.3

106.0

 

 

Income tax expense

848.9

448.2

1,883.2

1,419.4

 

 

Share of result of associates

(3.9)

(0.0)

(5.7)

(0.1)

 

Cash flow from operating activities before changes in working capital and use of provisions

4,241.1

3,855.9

11,202.8

10,302.4

 

 

Decrease/(increase) in trade and other receivables

(214.5)

(575.9)

(273.1)

(414.8)

 

 

Decrease/(increase) in inventories

95.2

64.4

(193.8)

(190.2)

 

 

Increase/(decrease) in trade and other payables

567.9

1,021.2

(1,745.7)

(1,324.6)

 

Cash generated from operations

4,689.8

4,365.6

8,990.1

8,372.8

 

 

Interest paid

(195.8)

(185.8)

(357.0)

(318.7)

 

 

Interest received

351.1

53.8

537.8

402.1

 

 

Dividends received

847.4

(29.7)

1,042.3

296.7

 

 

Income tax paid

(445.9)

(571.9)

(2,343.6)

(1,490.5)

 

Cash flow from operating activities

5,246.6

3,632.1

7,869.7

7,262.4

 

 

Proceeds from sale of property, plant, equipment and intangible assets

37.6

28.1

64.8

39.9

 

 

Acquisition of property, plant, equipment and intangible assets

(1,058.0)

(965.7)

(2,358.1)

(1,959.4)

 

 

Acquisition of subsidiaries, net of cash acquired

(75.6)

(59.7)

(245.0)

(2,513.1)

 

 

Investment in short term debt securities and net proceeds/(acquisition) of debt securities

(136.0)

(371.8)

(171.0)

(415.6)

 

 

Net proceeds/(acquisition) of other assets

-

(3.5)

(0.0)

(16.4)

 

Cash flow used in investing activities

(1,231.9)

(1,372.6)

(2,709.3)

(4,864.6)

 

 

Capital increase

-

173.4

160.3

199.7

 

 

Advancement for future capital increase

-

(170.5)

-

-

 

 

Proceeds from borrowings

(92.5)

479.4

191.8

1,128.7

 

 

Proceeds/repurchase of treasury shares

-

-

(8.9)

(20.2)

 

 

Repayment of borrowings

(80.0)

(1,588.9)

(729.8)

(2,907.6)

 

 

Cash net finance costs other than interests

(737.7)

(306.3)

(998.3)

(449.5)

 

 

Payment of finance lease liabilities

(0.3)

(0.9)

(1.1)

(5.0)

 

 

Dividends paid

(2,896.2)

(1,237.4)

(8,067.1)

(4,095.1)

 

Cash flow used in financing activities

(3,806.7)

(2,651.2)

(9,453.0)

(6,149.1)

 

Net increase/(decrease) in cash and cash equivalents

208.0

(391.8)

(4,292.6)

(3,751.3)

 

Cash and cash equivalents less bank overdrafts at beginning of period

4,435.8

4,890.2

8,926.0

8,063.9

 

Effect of exchange rate fluctuations

143.2

31.7

153.5

217.5

 

Cash and cash equivalents less bank overdrafts at end of period

4,787.0

4,530.2

4,787.0

4,530.2

               

 

 

 

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: October 31, 2013
     
 
COMPANHIA DE BEBIDAS DAS AMERICAS-AMBEV
     
 
By: 
/s/ Nelson Jose Jamel
 
Nelson Jose Jamel
Chief Financial and Investor Relations Officer
 
 
 
 

Comp DE Bebi AM (NYSE:ABV.C)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Comp DE Bebi AM 차트를 더 보려면 여기를 클릭.
Comp DE Bebi AM (NYSE:ABV.C)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Comp DE Bebi AM 차트를 더 보려면 여기를 클릭.